share_log

6-K: Blenrep Shows Significant Overall Survival Benefit, Reducing the Risk of Death by 42% in Multiple Myeloma at or After First Relapse

6-K: Blenrep Shows Significant Overall Survival Benefit, Reducing the Risk of Death by 42% in Multiple Myeloma at or After First Relapse

6-K:Blenrep顯示出顯着的總體生存益處,將多發性骨髓瘤患者首​​次復發時或復發後的死亡風險降低42%
美股SEC公告 ·  12/10 03:41
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息